Setrobuvir
Product Name :
Setrobuvir
Description:
Setrobuvir (ANA598) is an orally active non-nucleosidic HCV NS5B polymerase inhibitor. ANA-598 inhibits both de novo RNA synthesis and primer extension, with IC50s between 4 and 5 nM. Setrobuvir also shows excellent binding affinity to SARS-CoV-2 RdRp and induces RdRp inhibition.
CAS:
1071517-39-9
Molecular Weight:
560.62
Formula:
C25H25FN4O6S2
Chemical Name:
N-{3-[(1R,2S,7R,8S)-3-[(4-fluorophenyl)methyl]-6-hydroxy-4-oxo-3-azatricyclo[6.2.1.0²,⁷]undec-5-en-5-yl]-1,1-dioxo-4H-1λ⁶,2,4-benzothiadiazin-7-yl}methanesulfonamide
Smiles :
CS(=O)(=O)NC1=CC2=C(C=C1)NC(=NS2(=O)=O)C1=C(O)[C@H]2[C@H]([C@H]3C[C@@H]2CC3)N(CC2C=CC(F)=CC=2)C1=O
InChiKey:
DEKOYVOWOVJMPM-RLHIPHHXSA-N
InChi :
InChI=1S/C25H25FN4O6S2/c1-37(33,34)28-17-8-9-18-19(11-17)38(35,36)29-24(27-18)21-23(31)20-14-4-5-15(10-14)22(20)30(25(21)32)12-13-2-6-16(26)7-3-13/h2-3,6-9,11,14-15,20,22,28,31H,4-5,10,12H2,1H3,(H,27,29)/t14-,15+,20+,22-/m0/s1
Purity:
≥98% (or refer to the Certificate of Analysis)
Shipping Condition:
Shipped under ambient temperature as non-hazardous chemical or refer to Certificate of Analysis
Storage Condition :
Dry, dark and -20 oC for 1 year or refer to the Certificate of Analysis.
Shelf Life:
≥12 months if stored properly.{{Aprocitentan} medchemexpress|{Aprocitentan} GPCR/G Protein|{Aprocitentan} Protocol|{Aprocitentan} In stock|{Aprocitentan} custom synthesis|{Aprocitentan} Epigenetics}
Stock Solution Storage:
0 – 4 oC for 1 month or refer to the Certificate of Analysis.
Additional information:
Setrobuvir (ANA598) is an orally active non-nucleosidic HCV NS5B polymerase inhibitor. ANA-598 inhibits both de novo RNA synthesis and primer extension, with IC50s between 4 and 5 nM. Setrobuvir also shows excellent binding affinity to SARS-CoV-2 RdRp and induces RdRp inhibition.|Product information|CAS Number: 1071517-39-9|Molecular Weight: 560.62|Formula: C25H25FN4O6S2|Chemical Name: N-{3-[(1R,2S,7R,8S)-3-[(4-fluorophenyl)methyl]-6-hydroxy-4-oxo-3-azatricyclo[6.2.1.0²,⁷]undec-5-en-5-yl]-1,1-dioxo-4H-1λ⁶,2,4-benzothiadiazin-7-yl}methanesulfonamide|Smiles: CS(=O)(=O)NC1=CC2=C(C=C1)NC(=NS2(=O)=O)C1=C(O)[C@H]2[C@H]([C@H]3C[C@@H]2CC3)N(CC2C=CC(F)=CC=2)C1=O|InChiKey: DEKOYVOWOVJMPM-RLHIPHHXSA-N|InChi: InChI=1S/C25H25FN4O6S2/c1-37(33,34)28-17-8-9-18-19(11-17)38(35,36)29-24(27-18)21-23(31)20-14-4-5-15(10-14)22(20)30(25(21)32)12-13-2-6-16(26)7-3-13/h2-3,6-9,11,14-15,20,22,28,31H,4-5,10,12H2,1H3,(H,27,29)/t14-,15+,20+,22-/m0/s1|Technical Data|Appearance: Solid Power|Purity: ≥98% (or refer to the Certificate of Analysis)|Shipping Condition: Shipped under ambient temperature as non-hazardous chemical or refer to Certificate of Analysis|Storage Condition: Dry, dark and -20 oC for 1 year or refer to the Certificate of Analysis.{{Tafasitamab} site|{Tafasitamab} Apoptosis|{Tafasitamab} Technical Information|{Tafasitamab} Formula|{Tafasitamab} manufacturer|{Tafasitamab} Epigenetics} |Shelf Life: ≥12 months if stored properly.PMID:33314897 |Stock Solution Storage: 0 – 4 oC for 1 month or refer to the Certificate of Analysis.|Drug Formulation: To be determined|HS Tariff Code: 382200|How to use|In Vitro:|Setrobuvir (ANA598) is a non-nucleoside inhibitor that binds to the palm pocket of the HCV polymerase and has an EC50 against HCV genotype 1b/Con1-containing subgenomic replicons in the nanomolar range. Setrobuvir appears to inhibit both de novoinitiated RNA synthesis and primer extension, and its activity is unchanged by the presence of mutations that modify the activity of thumb-binding non-nucleoside inhibitors.|Products are for research use only. Not for human use.|